Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases

It is estimated that about 5–10% of ovarian and 2–5% of all breast cancer patients are carriers of a germline BRCA1 or BRCA2 gene mutation. Most families with detected BRCA1 or BRCA2 gene mutation are qualified for molecular testing on the basis of family history of breast or ovarian cancers. The pu...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Brozek, Izabela, Ratajska, Magdalena, Piatkowska, Magdalena, Kluska, Anna, Balabas, Aneta, Dabrowska, Michalina, Nowakowska, Dorota, Niwinska, Anna, Rachtan, Jadwiga, Steffen, Jan, Limon, Janusz
Format: Artigo
Langue:Inglês
Publié: Springer Netherlands 2012
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3496543/
https://ncbi.nlm.nih.gov/pubmed/22395474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10689-012-9519-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires